Millie
your market intelligence analyst
Search Results
316 results
Your search is now limited to «Sanofi» expert search.
Reuters.com 06/03/2020 13:29
Sanofi SA:
More from Reuters.com:
Reuters.com 06/03/2020 13:13
We will review available information and run consultations in the coming days to reassess our position,” a spokesman with Sanofi said.
More from Reuters.com:
GlobeNewswire 06/03/2020 12:00
Sanofi’s strategy aims at providing long-term growth and value for its stakeholders while turning innovation into transformative medicines for patients.
More from GlobeNewswire:
Sanofi secures EC approval for Sarclisa for third-line multiple myeloma.
More from Pharmaceutical Business Review:
ENDPOINTS 06/03/2020 07:36
In the relative short history of inflammasome research, Adam Keeney sees two time points marking major breakthroughs: the early 2000s, when the role of inflammasomes as a major innate immunity node was elucidated; and 2015, when Pfizer found out a compound it thought was targeting IL-1 actually blocks NLRP3.
More from ENDPOINTS:
FiercePharmaManufacturing 06/02/2020 11:42
Sanofi's Sarclisa, chasing Darzalex, brings the heat with big myeloma combo win.
More from FiercePharmaManufacturing:
CNBC - NetNet 06/02/2020 08:46
Sanofi CEO Paul Hudson joins "Squawk Box" to discuss the company's latest efforts in cancer research, the battle against Covid-19, selling the company's stake in Regeneron and more.
More from CNBC - NetNet:
Pharmafile 06/02/2020 07:33
Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in the treatment of relapsed or refractory multiple myeloma when combined with Pomalidomide and dexamethasone (pom-dex.
More from Pharmafile:
Motley Fool 05/29/2020 23:00
The malaria drug is quickly falling out of favor with the medical community as a potential treatment for the disease.
More from Motley Fool:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications